title: Comparison of taurine and pantoyltaurine as antioxidants in vitro and in the central nervous system of diabetic rats.
abstract: This study has comparatively evaluated the antiradical and antilipid peroxidizing actions of taurine (TAU) and its N-pantoyl analog pantoyltaurine (PTAU) in vitro, and has determined the extent to which these findings agree with the in vivo ability of these compounds to prevent changes in plasma glucose and in indices of oxidative stress in the plasma, brain and spinal cord induced by the diabetogen streptozotocin (STZ) in Sprague-Dawley rats. Using free radical-generating and oxidizing systems, PTAU was found more effective than TAU in scavenging DPPH, hydroxyl, peroxyl, and superoxide anion radicals and peroxynitrite, and in preventing lipid peroxidation of a brain homogenate by iron (III)-dopamine and the oxidation of dopamine by iron (III). On the other hand, when administered intraperitoneally (i.p.) at a 1.2mM/kg dose, 75min and 45min before a single i.p., 60mg/kg, dose of (STZ), TAU was about equipotent with PTAU in attenuating STZ-induced increases in glucose, malondialdehyde (MDA) and nitric oxide (NO), and the loss of reduced glutathione (GSH) in plasma collected at 24h post STZ. Moreover, the analysis of concurrently collected brain and spinal cords samples revealed that both TAU and PTAU were able to equally reverse the increases in MDA and NO concentrations and to effectively counteract the decrease in the GSH/GSSG ratio caused by STZ. Likewise, both compounds were very effective in preventing the losses of tissue catalase, glutathione peroxidase and superoxide dismutase activities. A comparison of the results for spinal cord and for brain parts such as the cerebellum, cortex and brain stem suggested the existence of regional differences in antioxidant potency between TAU and PTAU, especially in terms of antioxidant enzymes. In general, differences in antiradical and antioxidant potencies between TAU and PTAU derived from in vitro test are not reliable indicators of the antioxidant potencies these compounds may subsequently manifest in a living organism.
authors.affiliation: Department of Pharmaceutical Sciences, St. John's University, College of Pharmacy and Health Sciences, Jamaica, NY 11439, United States. Electronic address: sanketnpatel@yahoo.co.in.
authors.forename: Sanket N
authors.initials: SN
authors.lastname: Patel
authors.affiliation: Department of Pharmaceutical Sciences, St. John's University, College of Pharmacy and Health Sciences, Jamaica, NY 11439, United States. Electronic address: kashyap1983@yahoo.com.
authors.forename: Kashyap
authors.initials: K
authors.lastname: Pandya
authors.affiliation: Department of Pharmaceutical Sciences, St. John's University, College of Pharmacy and Health Sciences, Jamaica, NY 11439, United States. Electronic address: gjcrx@hotmail.com.
authors.forename: George J
authors.initials: GJ
authors.lastname: Clark
authors.affiliation: Department of Pharmaceutical Sciences, St. John's University, College of Pharmacy and Health Sciences, Jamaica, NY 11439, United States. Electronic address: parikh.mitul@gmail.com.
authors.forename: Mitul C
authors.initials: MC
authors.lastname: Parikh
authors.affiliation: Department of Pharmaceutical Sciences, St. John's University, College of Pharmacy and Health Sciences, Jamaica, NY 11439, United States. Electronic address: claucam@usa.net.
authors.forename: Cesar A
authors.initials: CA
authors.lastname: Lau-Cam
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects; D017207:Rats, Sprague-Dawley; D013116:Spinal Cord / Q000187:drug effects* / Q000378:metabolism; D013311:Streptozocin / Q000494:pharmacology; D013654:Taurine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D001786:Blood Glucose; D013654:Taurine; C003040:pantoyltaurine; D013311:Streptozocin
keywords: Antioxidant action; Comparison; In vitro; In vivo; Pantoyltaurine; Taurine